Form 8.3 - MEDICLINIC INTERNATIONAL PLC Amend
Source: RNS
FORM 8.3 |
Amendment to Purchase |
|
|
|
|
|
|
|
|||||||
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY |
|||||||
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR |
|||||||
MORE |
|||||||
Rule 8.3 of the Takeover Code (the "Code") |
|||||||
1. |
KEY INFORMATION |
||||||
(a) |
Full name of discloser: |
|
|
Barclays PLC. |
|||
|
|
|
|
|
|||
(b) |
Owner or controller of interest and short |
|
|||||
|
positions disclosed, if different from 1(a): |
||||||
(c) |
Name of offeror/offeree in relation to whose |
MEDICLINIC INTERNATIONAL PLC |
|||||
|
relevant securities this form relates: |
||||||
(d) |
If an exempt fund manager connected with an |
|
|||||
|
offeror/offeree, state this and specify identity of |
||||||
|
offeror/offeree: |
|
|
||||
(e) |
Date position held/dealing undertaken: |
30 November 2022 |
|||||
(f) |
In addition to the company in 1(c) above, is the discloser making |
NO |
|
|
|||
|
disclosures in respect of any other party to the offer? |
|
|
|
|||
2. |
POSITIONS OF THE PERSON MAKING THE DISCLOSURE |
||||||
(a) |
Interests and short positions in the relevant securities of the offeror or offeree |
||||||
|
to which the disclosure relates following the dealing (if any) |
|
|||||
Class of relevant security: |
10p ordinary |
|
|
||||
|
Interests |
Short Positions |
|||||
|
Number |
(%) |
Number |
(%) |
|||
(1) |
Relevant securities owned |
|
|
|
|
||
|
and/or controlled: |
13,564,220 |
1.84% |
5,462,127 |
0.74% |
||
|
|
|
|
|
|
|
|
(2) |
Cash-settled derivatives: |
|
|
|
|
||
|
|
|
4,266,445 |
0.58% |
9,852,447 |
1.34% |
|
|
|
|
|
|
|
|
|
(3) |
Stock-settled derivatives (including options) |
|
|
|
|
||
|
and agreements to purchase/sell: |
0 |
0.00% |
0 |
0.00% |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
TOTAL: |
|
17,830,665 |
2.42% |
15,314,574 |
2.08% |
|
|
|
|
|
|
|
|
|
(b) |
Rights to subscribe for new securities (including directors and other executive |
||||||
|
options) |
|
|
|
|
|
|
Class of relevant security in relation to |
|
||||||
which subscription right exists |
|
||||||
Details, including nature of the rights |
|
||||||
concerned and relevant percentages: |
|||||||
3. |
DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE |
||||||
(a) |
Purchases and sales |
|
|
|
|
|
|
Class of relevant |
Purchase/sale |
|
Number of |
|
Price per unit |
|
|
security |
|
|
|
securities |
|
|
|
10p ordinary |
Purchase |
1,193 |
4.9660 GBP |
||||
10p ordinary |
Purchase |
1,365 |
4.9577 GBP |
||||
10p ordinary |
Purchase |
1,780 |
4.9553 GBP |
||||
10p ordinary |
Purchase |
2,491 |
4.9608 GBP |
||||
10p ordinary |
Purchase |
3,541 |
4.9540 GBP |
||||
10p ordinary |
Purchase |
4,943 |
4.9575 GBP |
||||
10p ordinary |
Purchase |
5,031 |
4.9640 GBP |
||||
10p ordinary |
Purchase |
6,885 |
4.9517 GBP |
||||
10p ordinary |
Purchase |
9,529 |
4.9554 GBP |
||||
10p ordinary |
Purchase |
75,286 |
4.9529 GBP |
||||
10p ordinary |
Purchase |
104,178 |
4.9520 GBP |
||||
10p ordinary |
Sale |
238 |
4.9560 GBP |
||||
10p ordinary |
Sale |
801 |
4.9540 GBP |
||||
10p ordinary |
Sale |
1,087 |
4.9580 GBP |
||||
10p ordinary |
Sale |
1,161 |
4.9510 GBP |
||||
10p ordinary |
Sale |
1,283 |
4.9602 GBP |
||||
10p ordinary |
Sale |
1,649 |
4.9593 GBP |
||||
10p ordinary |
Sale |
1,650 |
4.9532 GBP |
||||
10p ordinary |
Sale |
2,193 |
4.9600 GBP |
||||
10p ordinary |
Sale |
5,852 |
4.9519 GBP |
||||
10p ordinary |
Sale |
7,109 |
4.9522 GBP |
||||
10p ordinary |
Sale |
7,835 |
4.9573 GBP |
||||
10p ordinary |
Sale |
21,961 |
4.9568 GBP |
||||
10p ordinary |
Sale |
29,667 |
4.9559 GBP |
||||
10p ordinary |
Sale |
36,965 |
4.9528 GBP |
||||
10p ordinary |
Sale |
41,276 |
4.9516 GBP |
||||
10p ordinary |
Sale |
75,029 |
4.9520 GBP |
||||
|
|
|
|
|
|
|
|
(b) |
Cash-settled derivative transactions |
|
|
|
|||
Class of |
|
Product |
|
Nature of dealing |
|
Number of |
Price per |
relevant |
|
description |
|
|
|
reference |
unit |
security |
|
|
|
|
|
securities |
|
10p ordinary |
SWAP |
Long |
238 |
4.9560 GBP |
|||
10p ordinary |
SWAP |
Long |
670 |
4.9600 GBP |
|||
10p ordinary |
CFD |
Long |
682 |
100.3464 ZAR |
|||
10p ordinary |
SWAP |
Long |
1,492 |
4.9589 GBP |
|||
10p ordinary |
SWAP |
Long |
1,649 |
4.9593 GBP |
|||
10p ordinary |
SWAP |
Long |
1,650 |
4.9532 GBP |
|||
10p ordinary |
SWAP |
Long |
2,012 |
100.3613 ZAR |
|||
10p ordinary |
SWAP |
Long |
2,336 |
4.9570 GBP |
|||
10p ordinary |
CFD |
Long |
4,275 |
4.9520 GBP |
|||
10p ordinary |
SWAP |
Long |
5,852 |
4.9519 GBP |
|||
10p ordinary |
SWAP |
Long |
15,212 |
4.9610 GBP |
|||
10p ordinary |
SWAP |
Long |
16,760 |
100.1331 ZAR |
|||
10p ordinary |
CFD |
Long |
16,835 |
4.9529 GBP |
|||
10p ordinary |
SWAP |
Long |
29,667 |
4.9559 GBP |
|||
10p ordinary |
SWAP |
Long |
34,904 |
100.0500 ZAR |
|||
10p ordinary |
SWAP |
Long |
41,276 |
4.9516 GBP |
|||
10p ordinary |
SWAP |
Long |
82,397 |
100.0528 ZAR |
|||
10p ordinary |
SWAP |
Long |
126,854 |
100.0518 ZAR |
|||
10p ordinary |
SWAP |
Short |
73 |
4.9580 GBP |
|||
10p ordinary |
SWAP |
Short |
682 |
100.3740 ZAR |
|||
10p ordinary |
SWAP |
Short |
2,012 |
100.3613 ZAR |
|||
10p ordinary |
CFD |
Short |
2,083 |
100.5715 ZAR |
|||
10p ordinary |
SWAP |
Short |
4,943 |
4.9575 GBP |
|||
10p ordinary |
SWAP |
Short |
6,299 |
4.9604 GBP |
|||
10p ordinary |
SWAP |
Short |
11,236 |
4.9553 GBP |
|||
10p ordinary |
CFD |
Short |
16,760 |
100.1632 ZAR |
|||
10p ordinary |
SWAP |
Short |
34,725 |
4.9538 GBP |
|||
10p ordinary |
CFD |
Short |
34,904 |
100.0775 ZAR |
|||
10p ordinary |
SWAP |
Short |
44,342 |
4.9533 GBP |
|||
10p ordinary |
SWAP |
Short |
82,397 |
100.0528 ZAR |
|||
10p ordinary |
SWAP |
Short |
126,854 |
100.0518 ZAR |
|||
|
|
|
|
|
|
|
|
(c) |
Stock-settled derivative transactions (including options) |
|
|
||||
(i) |
Writing, selling, purchasing or varying |
|
|
|
|||
Class |
Product |
Writing, |
Number |
Exercise |
Type |
Expiry |
Option |
of |
description |
purchasing, |
of |
price |
|
date |
money |
relevant |
|
selling, |
securities |
per unit |
|
|
paid/ |
security |
|
varying etc |
to which |
|
|
|
received |
|
|
|
option |
|
|
|
per unit |
|
|
|
relates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii) |
Exercising |
|
|
|
|
|
|
Class of relevant |
Product description |
Exercising/ exercised against |
Number of |
Exercise price per |
|||
security |
|
|
|
securities |
unit |
||
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
(d) |
Other dealings (including subscribing for new securities) |
|
|
||||
Class of relevant |
Nature of Dealings |
|
Details |
Price per unit (if |
|
||
security |
|
|
|
applicable) |
|
||
|
|
|
|
||||
4. |
OTHER INFORMATION |
||||||
(a) |
Indemnity and other dealings arrangements |
|
|
|
|||
Details of any indemnity or option arrangement, or any agreement or understanding, |
|||||||
formal or informal, relating to relevant securities which may be an inducement to deal |
|||||||
or refrain from dealing entered into by the person making the disclosure and any party |
|||||||
to the offer or any person acting in concert with a party to the offer: |
|
|
|||||
NONE |
|||||||
(b) |
Agreements, arrangements or understandings relating to options or derivatives |
||||||
Details of any agreement, arrangement or understanding, formal or informal, between |
|||||||
the person making the disclosure and any other person relating to: |
|
|
|||||
(i) the voting rights of any relevant securities under any option; or |
|
|
|||||
(ii) the voting rights of future acquisition or disposal of any relevant securities to which |
|||||||
any derivative is referenced: |
|
|
|
|
|
||
NONE |
|||||||
(c) |
Attachments |
|
|
|
|
|
|
Is a Supplemental Form 8 (Open Positions) attached? |
NO |
||||||
Date of disclosure: |
6 Dec 2022 |
|
|
|
|||
Contact name: |
Large Holdings Regulatory Operations |
||||||
Telephone number: |
020 3134 7213 |
|
|
||||
|
|
|
|
|
|
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.